These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21552521)

  • 1. HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy.
    van Dijk JH; Sutcliffe CG; Munsanje B; Sinywimaanzi P; Hamangaba F; Thuma PE; Moss WJ
    PLoS One; 2011 Apr; 6(4):e19006. PubMed ID: 21552521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis.
    van Dijk JH; Sutcliffe CG; Munsanje B; Hamangaba F; Thuma PE; Moss WJ
    BMC Infect Dis; 2009 Oct; 9():169. PubMed ID: 19835604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for pre-treatment mortality among HIV-infected children in rural Zambia: a cohort study.
    Sutcliffe CG; van Dijk JH; Munsanje B; Hamangaba F; Siniwymaanzi P; Thuma PE; Moss WJ
    PLoS One; 2011; 6(12):e29294. PubMed ID: 22216237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaling-up access to antiretroviral therapy for children: a cohort study evaluating care and treatment at mobile and hospital-affiliated HIV clinics in rural Zambia.
    van Dijk JH; Moss WJ; Hamangaba F; Munsanje B; Sutcliffe CG
    PLoS One; 2014; 9(8):e104884. PubMed ID: 25122213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcomes among children younger than five years living with HIV in rural Zambia, 2008-2018: a cohort study.
    Schue JL; van Dijk JH; Hamangaba F; Hamahuwa M; Moyo N; Thuma PE; Moss WJ; Sutcliffe CG
    BMC Pediatr; 2021 Jul; 21(1):315. PubMed ID: 34261465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of efavirenz-based regimens in young HIV-infected children treated for tuberculosis: a treatment option for resource-limited settings.
    van Dijk JH; Sutcliffe CG; Hamangaba F; Bositis C; Watson DC; Moss WJ
    PLoS One; 2013; 8(1):e55111. PubMed ID: 23372824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight and height z-scores improve after initiating ART among HIV-infected children in rural Zambia: a cohort study.
    Sutcliffe CG; van Dijk JH; Munsanje B; Hamangaba F; Sinywimaanzi P; Thuma PE; Moss WJ
    BMC Infect Dis; 2011 Mar; 11():54. PubMed ID: 21362177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secular trends in pediatric antiretroviral treatment programs in rural and urban Zambia: a retrospective cohort study.
    Sutcliffe CG; Bolton-Moore C; van Dijk JH; Cotham M; Tambatamba B; Moss WJ
    BMC Pediatr; 2010 Jul; 10():54. PubMed ID: 20673355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.
    Okomo U; Togun T; Oko F; Peterson K; Townend J; Peterson I; Jaye A
    BMC Pediatr; 2012 Jul; 12():95. PubMed ID: 22770231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.
    Bolton-Moore C; Mubiana-Mbewe M; Cantrell RA; Chintu N; Stringer EM; Chi BH; Sinkala M; Kankasa C; Wilson CM; Wilfert CM; Mwango A; Levy J; Abrams EJ; Bulterys M; Stringer JS
    JAMA; 2007 Oct; 298(16):1888-99. PubMed ID: 17954540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased vulnerability of rural children on antiretroviral therapy attending public health facilities in South Africa: a retrospective cohort study.
    Fatti G; Bock P; Grimwood A; Eley B
    J Int AIDS Soc; 2010 Nov; 13():46. PubMed ID: 21108804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and virologic outcomes after access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia.
    Kuhn L; Semrau K; Ramachandran S; Sinkala M; Scott N; Kasonde P; Mwiya M; Kankasa C; Decker D; Thea DM; Aldrovandi GM
    J Acquir Immune Defic Syndr; 2009 Sep; 52(1):132-6. PubMed ID: 19506483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of early initiated antiretroviral therapy in sub-Saharan children: a Cameroonian cohort study (ANRS-12140 Pediacam study, 2008-2013, Cameroon).
    Ndongo FA; Tejiokem MC; Penda CI; Ndiang ST; Ndongo JA; Guemkam G; Sofeu CL; Tagnouokam-Ngoupo PA; Kfutwah A; Msellati P; Faye A; Warszawski J
    BMC Pediatr; 2021 Apr; 21(1):189. PubMed ID: 33882903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in Zimbabwe.
    Makadzange AT; Higgins-Biddle M; Chimukangara B; Birri R; Gordon M; Mahlanza T; McHugh G; van Dijk JH; Bwakura-Dangarembizi M; Ndung'u T; Masimirembwa C; Phelps B; Amzel A; Ojikutu BO; Walker BD; Ndhlovu CE
    PLoS One; 2015; 10(12):e0144057. PubMed ID: 26658814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in the characteristics and outcomes of children living with HIV following universal ART in sub-Saharan Africa (2006-17): a retrospective cohort study.
    Iyun V; Technau KG; Vinikoor M; Yotebieng M; Vreeman R; Abuogi L; Desmonde S; Edmonds A; Amorissani-Folquet M; Davies MA;
    Lancet HIV; 2021 Jun; 8(6):e353-e362. PubMed ID: 33932330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa.
    Nachega JB; Hislop M; Nguyen H; Dowdy DW; Chaisson RE; Regensberg L; Cotton M; Maartens G
    J Acquir Immune Defic Syndr; 2009 May; 51(1):65-71. PubMed ID: 19282780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.
    Maskew M; Fox MP; van Cutsem G; Chu K; Macphail P; Boulle A; Egger M; Africa FI
    PLoS One; 2013; 8(6):e64392. PubMed ID: 23755122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of poor CD4 and weight recovery in HIV-infected children initiating ART in South Africa.
    Zanoni BC; Phungula T; Zanoni HM; France H; Cook EF; Feeney ME
    PLoS One; 2012; 7(3):e33611. PubMed ID: 22438965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.